Quick Facts at a Glance
- Recall Date
- October 9, 2025
- Hazard Level
- HIGH
- Brand
- STAQ Pharma
- Category
- Health & Personal Care
- Sold At
- Unknown
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- STAQ Pharma
- Product type
- Intravenous injection solution
- Model numbers
- Lot: 25102464B, 25102370A, 25102369A
- Sold at
- Unknown
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
October 9, 2025
Reported by FDA DRUG
October 22, 2025
RecallRadar source check
April 18, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Labeling: Incorrect or Missing Lot and/or Exp Date
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact STAQ Pharma, Inc. or your healthcare provider for guidance. Notification method: Letter
About This Product
FentaNYL Citrate PF is an injectable fentanyl product used for analgesia in clinical settings. It is supplied in 50 mL syringes for IV administration.
Why This Is Dangerous
Labeling errors can cause administration of the wrong lot or an expired product, potentially compromising safety.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Hospitals and clinics must verify lot numbers and expiration dates to avoid dosing errors and ensure proper traceability.
Practical Guidance
How to identify if yours is affected
- Check the packaging for NDC 73177-0102-05.
- Check Lot: 25102464B, 25102370A, 25102369A.
- Verify expiration date on the package.
Where to find product info
Recall notice on FDA enforcement page and manufacturer communications.
What timeline to expect
Recall letters will provide replacement or refund instructions; timeline not specified.
If the manufacturer is unresponsive
- Document attempts to contact the manufacturer.
- File a complaint with the FDA if needed.
How to prevent similar issues
- Verify labeling for all drug orders before administration.
- Keep shelves organized to avoid using misdated lots.
- Use standard hospital recall procedures for drug validation.
Documentation advice
Keep recall letter, photos of the packaging, lot numbers, and NDC; record communications with the manufacturer.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
Product: FentaNYL Citrate PF IV injection, 500mcg/50mL (10mcg/mL) in NaCl, 50 mL syringe. Brand: STAQ Pharma. NDC: 73177-0102-05. Lot numbers: 25102369A, 25102370A, 25102464B. Sold nationwide in the U.S.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
- Recall date 2025-10-09; status ACTIVE
- Hazard level HIGH
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
